Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENT OF CASH FLOWS

v3.19.1
CONSOLIDATED STATEMENT OF CASH FLOWS - USD ($)
 12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Cash flows from operating activities:    
Net loss $ (3,093,900) $ (2,744,000)
Income from discontinued operations 41,000 3,389,600
Net loss from continuing operations (3,134,900) [1] (6,133,600)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Depreciation, amortization and impairment 541,300 774,800
Stock-based compensation expense 101,400 246,600
Stock issued for services 102,000  
Non-cash expense for interest, common stock issued for debt penalty 1,226,900 1,147,000
Note receivable discount (39,400)  
Impairment of patent costs 19,200  
Provision for doubtful accounts receivable (232,600) 224,600
Cost of sale of equipment to joint venture   316,800
Settlement expense   254,900
Gain on debt extinguishment (128,000)  
Impairment of assets 70,700 676,000
Changes in operating assets and liabilities:    
Accounts receivable (138,500) 271,100
Costs in Excess of billings on uncompleted contracts (314,300) 13,600
Prepaid expenses and other assets 332,900 593,800
Accounts payable and accrued liabilities 463,600 (279,800)
Billings in excess of revenue on uncompleted contracts 242,900 (863,500)
Customer deposits (20,000) 21,600
Deferred revenue (162,600) (54,600)
Payroll taxes payable 24,800 4,400
Net cash provided by operating activities (1,044,600) (2,786,300)
Cash flows from investing activities:    
Purchase of property and equipment (60,300) (199,800)
Proceeds from sale of discontinued operations, net of costs   2,510,900
Proceeds from the sale of property and equipment   74,300
Purchase of intangible assets (100) (18,600)
Proceeds from outside minority investment in new subsidiary 450,000  
Proceeds from notes receivable 224,000  
Distributions for notes receivable   (300,000)
Net cash provided by investing activities 613,600 2,066,800
Cash flows from financing activities:    
Principal payments of notes and capital lease obligations (818,400) (1,468,000)
Proceeds from issuance of convertible and short-term debt 850,000 1,275,000
Proceeds from the extension of warrants   155,500
Proceeds from the sale of common stock and warrants, net of expenses 420,000  
Net cash provided by (used in) financing activities 451,600 (37,500)
Net cash flows from discontinued operations 41,000 577,900
Net increase (decrease) in cash 61,600 (179,100)
Cash at the beginning of year 54,100 233,200
Cash at the end of year 115,700 54,100
Supplemental disclosures of cash flow information:    
Cash paid for income taxes  
Cash paid for interest 12,100 211,600
Supplemental disclosure of noncash financing and investing activities:    
Financed equipment   88,400
Financing of insurance premiums $ 373,900 $ 438,300
[1] Excludes discontinued operations